These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38569687)

  • 1. Implementation of an intervention aimed at deprescribing benzodiazepines in a large US healthcare system using patient education materials: a pre/post-observational study with a control group.
    Le TM; Campbell S; Andraos A; Ahlmark P; Hoang H; Isserman S; Goldzweig CL; Mays AM; Bradley K; Keller MS
    BMJ Open; 2024 Apr; 14(4):e080109. PubMed ID: 38569687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a benzodiazepine deprescribing quality improvement initiative for older adults in primary care.
    Chae S; Lee E; Lindenberg J; Shen K; Anderson TS
    J Am Geriatr Soc; 2024 Apr; 72(4):1234-1241. PubMed ID: 38147454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A realist evaluation of patients' decisions to deprescribe in the EMPOWER trial.
    Martin P; Tannenbaum C
    BMJ Open; 2017 May; 7(4):e015959. PubMed ID: 28473524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adapting the Eliminating Medications Through Patient Ownership of End Results Protocol to Promote Benzodiazepine Cessation Among US Military Veterans: Focus Group Study With US Military Veterans and National Veterans Health Administration Leaders.
    Cucciare MA; Abraham TH; Kemp L; White P; Marchant K; Hagedorn HJ; Humphreys K
    J Med Internet Res; 2022 Sep; 24(9):e35514. PubMed ID: 36121697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial.
    Tannenbaum C; Martin P; Tamblyn R; Benedetti A; Ahmed S
    JAMA Intern Med; 2014 Jun; 174(6):890-8. PubMed ID: 24733354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deprescribing benzodiazepines among hospitalised older adults: quality improvement initiative.
    Carr F; Tian P; Chow J; Guzak J; Triscott J; Mathura P; Sun X; Dobbs B
    BMJ Open Qual; 2019; 8(3):e000539. PubMed ID: 31523732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility and perceptions of a benzodiazepine deprescribing quality improvement initiative for primary care providers in Japan.
    Nishimura M; Teo AR; Mochizuki T; Fujiwara N; Nakamura M; Yamashita D
    BMC Prim Care; 2024 Jan; 25(1):35. PubMed ID: 38267882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the EMPOWER brochure to deprescribe sedative-hypnotic drugs in older adults with mild cognitive impairment.
    Martin P; Tannenbaum C
    BMC Geriatr; 2017 Jan; 17(1):37. PubMed ID: 28143413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers, facilitators and needs to deprescribe benzodiazepines and other sedatives in older adults: a mixed methods study of primary care provider perspectives.
    Hürlimann O; Alers D; Hauri N; Leist P; Schneider C; Bolt L; Rodondi N; Aubert CE
    BMC Geriatr; 2024 May; 24(1):396. PubMed ID: 38704540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A health-system-embedded deprescribing intervention targeting patients and providers to prevent falls in older adults (STOP-FALLS trial): study protocol for a pragmatic cluster-randomized controlled trial.
    Balderson BH; Gray SL; Fujii MM; Nakata KG; Williamson BD; Cook AJ; Wellman R; Theis MK; Lewis CC; Key D; Phelan EA
    Trials; 2023 May; 24(1):322. PubMed ID: 37170329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct-to-consumer strategies to promote deprescribing in primary care: a pilot study.
    Linsky AM; Kressin NR; Stolzmann K; Pendergast J; Rosen AK; Bokhour BG; Simon SR
    BMC Prim Care; 2022 Mar; 23(1):53. PubMed ID: 35317734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Benzoletter: minimal intervention for deprescribing benzodiazepines in patients with insomnia].
    Baza Bueno M; Ruiz de Velasco Artaza E; Fernández Uria J; Gorroñogoitia Iturbe A
    Gac Sanit; 2020; 34(6):539-545. PubMed ID: 31784194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deprescribing Education vs Usual Care for Patients With Cognitive Impairment and Primary Care Clinicians: The OPTIMIZE Pragmatic Cluster Randomized Trial.
    Bayliss EA; Shetterly SM; Drace ML; Norton JD; Maiyani M; Gleason KS; Sawyer JK; Weffald LA; Green AR; Reeve E; Maciejewski ML; Sheehan OC; Wolff JL; Kraus C; Boyd CM
    JAMA Intern Med; 2022 May; 182(5):534-542. PubMed ID: 35343999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An educational intervention to reduce the use of potentially inappropriate medications among older adults (EMPOWER study): protocol for a cluster randomized trial.
    Martin P; Tamblyn R; Ahmed S; Tannenbaum C
    Trials; 2013 Mar; 14():80. PubMed ID: 23514019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deprescribing benzodiazepine receptor agonists in older adults: a mixed-methods study to adapt the Canadian D-PRESCRIBE intervention to the Belgian community setting.
    Pétein C; Dujardin N; de Montigny M; Dewez E; Spinewine A; Henrard S
    BMJ Open; 2024 Aug; 14(8):e085396. PubMed ID: 39153767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid stewardship: implementing a proactive, pharmacist-led intervention for patients coprescribed opioids and benzodiazepines at an urban academic primary care centre.
    Tilli T; Hunchuck J; Dewhurst N; Kiran T
    BMJ Open Qual; 2020 Apr; 9(2):. PubMed ID: 32269056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying barriers and facilitators to deprescribing benzodiazepines and sedative hypnotics in the hospital setting using the Theoretical Domains Framework and the Capability, Opportunity, Motivation and Behaviour (COM-B) Model: a qualitative study.
    Keller MS; Carrascoza-Bolanos J; Breda K; Kim LY; Kennelty KA; Leang DW; Murry LT; Nuckols TK; Schnipper JL; Pevnick JM
    BMJ Open; 2023 Feb; 13(2):e066234. PubMed ID: 36813499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-Directed Education to Promote Deprescribing: A Nonrandomized Clinical Trial.
    Jones KF; Stolzmann K; Wormwood J; Pendergast J; Miller CJ; Still M; Bokhour BG; Hanlon J; Simon SR; Rosen AK; Linsky AM
    JAMA Intern Med; 2024 Nov; 184(11):1339-1346. PubMed ID: 39312257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leveraging policy to reduce chronic opioid use by educating and empowering community dwelling adults: a study protocol for the TAPERING randomized controlled trial.
    Turner JP; Caetano P; Tannenbaum C
    Trials; 2019 Jul; 20(1):412. PubMed ID: 31288859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.